Multiple growth factors synergistically stimulate proliferation of primitive hematopoietic progenitor cells. A human myeloid cell line, KPB-M15, constitutively produces a novel hematopoietic cytokine, termed stem cell growth factor (SCGF), possessing species-specific proliferative activities. Here we report the molecular cloning, expression, and characterization of a cDNA encoding human SCGF using a newly developed SHDM vector that is more efficient for differential and expression cloning. cDNA for SCGF encodes a 29-kDa polypeptide without N-linked glycosylation. SCGF transiently produced by COS-1 cells supports growth of hematopoietic progenitor cells through a short-term liquid culture of bone marrow cells and exhibits promoting activities on erythroid and granulocyte͞macrophage progenitor cells in primary semisolid culture with erythropoietin and granulocyte͞ macrophage colony-stimulating factor, respectively. Expression of SCGF mRNA is restricted to myeloid cells and fibroblasts, suggesting that SCGF is a growth factor functioning within the hematopoietic microenvironment. SCGF could disclose some human-specific mechanisms as yet unidentified from studies on the murine hematopoietic system.
Mature blood cells are supplied through a hematopoietic hierarchy from self-renewable stem cells down to committed progenitors. Primitive hematopoietic progenitor cells are redundantly stimulated by multiple pleiotropic cytokines, including colony-stimulating factors (CSFs) and interleukins (ILs), the synergistic action of which is required for the proliferation of more primitive progenitor cells (1) . Stem cell factor (SCF or c-kit ligand) (2-4) and flk-2͞flt3 ligand (L) (5) are thought to be key molecules among the cooperative regulators.
Stem cell growth factor (SCGF) was originally detected in mitogen-stimulated leukocyte conditioned medium (CM) (6) and constitutively elaborated by a human myeloid cell line, KPB-M15, derived from chronic myelogenous leukemia in blast crisis (7) . It lacks colony-stimulating activity, but has burst-promoting activity (BPA) for human bone marrow (BM) erythroid progenitors (burst-forming unit erythroid), granulocyte͞macrophage (GM)-promoting activity (GPA) for GM progenitors [colony-forming unit (CFU)-GM] and a CFU-GM-sustaining or recruiting effect during short-term liquid BM cell culture (⌬GPA).
Human BM cell-dependent assay system is indeed a big hurdle for further characterization of SCGF. However, preliminary studies have shown that human SCGF is strictly species-specific; therefore, screening cDNA samples and fractions at each purification step need to be assessed for BPA not on murine cells but on human BM cells. CD34
ϩ BM cell populations are a likely target for BPA assay but are impractical for repetitive experiments for quite a few samples because sufficient BM cells are not available due to a limited number of donors. KPB-M15 cells secrete a significant level of IL-6, but neither produce IL-1␣, IL-1␤, IL-3, IL-4, G-CSF or GM-CSF, nor express mRNA for IL-11, leukemia inhibitory factor, SCF, or flk-2͞flt3 L, as evidenced by ELISA and reverse transcription-PCR analyses. IL-6 alone never exhibits BPA, and anti-IL-6 antibody has little effect on BPA in KPB-M15-CM, inferring that SCGF activities are not mediated by IL-6 (A.H., A.S., and N.O., unpublished observations). These findings indicate that BPA, GPA, and ⌬GPA assay systems are suitable for examining direct activities of SCGF on primitive hematopoietic progenitor cells even in nonseparated BM cells.
(9) via CDMflit, as described (A.S., A.H., and S.S., unpublished work).
Differential Cloning of SCGF cDNA by Subtractive Probe. SHDM(KPB) phage in SURE E. coli plaques was transferred to duplicate nitrocellulose filters (10) (11) (12) . The phage DNA fixed on each filter was hybridized with 32 P-labeled (ϩ) and (Ϫ) probes (13) . The (ϩ) probe was KPB-M15 cDNA subtracted with MOLT-4 mRNA; single-stranded cDNA, synthesized from KPB-M15 mRNA (14) , was annealed with an excess of MOLT-4 mRNA at 65°C for Ն40 hr, and fractions flowing through hydroxyapatite were collected (15) . MOLT-4 singlestranded cDNA was used as the (Ϫ) probe. The 32 P-labeled single-stranded cDNA probes were prepared using the Multiprime DNA labeling system (Amersham). The KPB-M15-specific differential phage library was made of clones both positive for the (ϩ) probe and negative for the (Ϫ) probe. The selected phage clones were coinfected with helper phage R408 into XL1-Blue E. coli, replicating to circularize the region between M13 initiator and terminator of SHDM vector to develop pSHDM cDNA-carrying phagemid. The phagemid was infected into MC1061͞P3͞PCJ E. coli (at 37°C for 15 min), established by transformation of MC1061͞P3 E. coli with CJ236 E. coli-derived PCJ105. Plasmid DNA was prepared from ampicillin͞tetracyclin-resistant colonies by alkaline lysis procedure (16, 17) , and digested with EcoRI and XhoI.
Transient Gene Expression in COS-1 Cells. Plasmid cDNA was purified by equilibrium centrifugation in CsCl-ethidium bromide gradients. COS-1 cells (10 6 ) were transfected at 37°C for 5 hr with 0.3-3 g͞ml plasmid cDNA in 100 g͞ml DEAE-dextran͞100 M chloroquine͞DMEM. They were incubated at room temperature for 2 min in 10% dimethyl sulfoxide͞10% FCS͞DMEM and then cultured overnight in 10% FCS͞DMEM. Another cycle of transfection was followed by 2-to 3-day cultures in serum-free DMEM. Double transfection enhanced gene expression to twice the level by single procedure.
Northern Blot Analysis. Total RNA (20 g) from each human cell line was electrophoresed on a 2.2 M formaldehyde͞1% agarose gel and transferred to a nitrocellulose filter (18) . The RNA blots and the filter fixed with poly(A) ϩ RNA from various human tissues (Human Multiple Tissue Northern Blots; CLONTECH) were hybridized with fluorescein-labeled pSHDM(116-10C) cDNA fragments covering the 5Ј noncoding and most of the coding region (from EcoRI to the first XhoI site in Fig. 2 A) , and analyzed with the Gene Images detection system (Amersham).
Assay for Hematopoietic Activities. Human BM cells were aspirated from the sternum of healthy volunteers after obtaining informed consent. Semisolid culture (1 ml) for BPA and GPA assay contained 5 ϫ 10 4 nonadherent BM cells at a density of Ͻ1.077 g͞ml in 2.5-20% samples͞5 ϫ 10 Ϫ5 M 2-mercaptoethanol͞20% FCS͞Iscove's modified Dulbecco's medium͞0.3% Bacto agar with 1 unit͞ml recombinant human (rh) erythropoietin (Espo; Kirin, Tokyo) and 5 ng͞ml rhGM-CSF (Genzyme), respectively (6) . The preparations were incubated at 37°C under 5% CO 2 ͞100% H 2 O in air for 14 and 10 days, and then erythroid bursts and GM colonies were enumerated. For ⌬GPA assay, an initial 7-day liquid culture of 5 ϫ 10 5 ͞ml BM cells in 2.5-20% samples͞10% FCS͞Iscove's modified Dulbecco's medium was followed by a secondary semisolid 10-day CFU-GM culture of the harvested cells with 10 ng͞ml rhGM-CSF.
Purification of SCGF from KPB-M15-CM. Serum-free KPB-M15-CM (1,500 ml) was diluted with H 2 O (9,750 ml) and applied to a DEAE-Sephacel column (5 cm ϫ 6.1 cm; diameter ϫ height) equilibrated with 0.01% Tween 80͞20 mM Hepes-NaOH (pH 6.0) (all buffers used contained 0.01% Tween 80). Fractions eluted with a linear gradient of 0.1-0.25 M NaCl were next applied to Cu 2ϩ chelating-Sepharose column (1.6 cm ϫ 4 cm; diameter ϫ height) equilibrated with 20 mM Hepes-NaOH (pH 7.4). Fractions eluted with a linear gradient of 0.05-0.1 M glycine were reconcentrated through a mini-DEAE-Sephacel column (1.6 cm ϫ 0.5 cm; diameter ϫ height). The condensed fractions were applied to Sephacryl S-200HR column (1.6 cm ϫ 64 cm; diameter ϫ height) equilibrated with 20 mM Hepes-NaOH (pH 7.0).
RESULTS AND DISCUSSION
We developed a new phage cloning vector, SHDM (A.S., A.H., and S.S., unpublished work) more effective for differential and expression cloning (19, 20) . It was characterized as being intrinsically convertible without any enzymatic manipulation; from a phage vector where cDNA could hybridize with differential probes, to a plasmid vector pSHDM where cDNA could be expressed in mammalian cells. The SHDM vector possessed human T-lymphotropic virus type I long terminal repeat (R͞U5)͞simian virus 40 (SV40) early promoter (21), SV40 16S splice junction͞SV40 early splice, and poly(A) signal segment for expressing foreign genes efficiently in mammalian cells, pBR322 origin of replication that could be replicated in E. coli, and Sup F, a selection marker in p3 vector-harboring E. coli (9) located between M13 initiator and terminator flanked by phage-derived left and right arms (Fig. 1) . cDNA inserted into the EcoRI-XhoI site could be oriented so as to be subject to upper human T-lymphotropic virus type I long terminal repeat (R͞U5)͞SV40 early promoter.
About 120,000 cDNA clones were prepared from KPB-M15 cells as the starting cohort. These were sorted to Ϸ14,400 based on hybridization with KPB-M15 cDNA subtracted with MOLT-4 mRNA, but not with cDNA from SCGF-infertile MOLT-4 cells. The clones were distributed individually, 48 to a pool, to make up a total of 300 pools. For 137 pools at the first screening, mixed plasmid cDNA from each pool was transfected into COS-1 cells, and CM was concentrated 7-to 8-fold through DEAE-Sephacel (pH 6). A total of 192 clones from 4 pools were selected as positive for BPA and directly stepped up to a secondary trial, where samples from single plasmid cDNA were screened as untreated. The sample from pSHDM(116-10C) cDNA presented the highest BPA at the second screening. Double-stranded pSHDM(116-10C) cDNA was sequenced according to the strategy outlined in Fig. 2A . It was demonstrated to have an open reading frame encoding a novel polypeptide.
The sample from pSHDM(116-10C) cDNA also exhibited distinct dose-dependent GPA and ⌬GPA (Fig. 3) . Its BPA and GPA were 2-to 4-fold higher than that of original KPB-M15-CM. In the presence of erythropoietin or GM-CSF, the sample from pSHDM(116-10C) cDNA formed colonies identical in morphology and size with those grown with KPB-M15-CM. The findings therefore confirmed that pSHDM(116-10C) cDNA encoded SCGF as a factor possessing BPA, GPA, and ⌬GPA in KPB-M15-CM. SCGF exhibited less BPA than SCF, as evidenced by the number and size of erythroid bursts, and moderate GPA, indicating that the target cell population for SCGF differed from that for SCF. SCGF resembles flk-2͞flt3 L in that it has no definite colony-stimulating activity on hematopoietic progenitor cells, while the latter is devoid of erythroid lineage-specific BPA (5). SCGF alone could not support colony formation-i.e., SCGF did not stimulate colony growth in culture containing only SCGF except in 20% FCS͞Iscove's modified Dulbecco's medium.
Human SCGF cDNA had 1,196 nucleotides containing a long open reading frame of 738 nucleotides that encoded a 245-amino acid polypeptide (Fig. 2B) . No homology with the database in the EMBL, GenBank and Swiss-Prot was found for the SCGF cDNA and amino acid sequence. About 20 amino acids, starting from initiation methionine, were hydrophobic (Fig. 2C ), corresponding to a putative signal peptide. Unlike in most hematopoietic growth factors with the exception of G-CSF (23) and IL-11 (24) , there existed no consensus sequence of potential NH 2 -glycosylation sites (Asn-Xnn-Thr͞ Ser). In fact, SCGF bound neither to Con A-Sepharose nor to WGA-agarose (data not shown). The minimal molecular mass of SCGF was calculated to be 29,038 Da. Five cysteine residues were located close to the carboxyl terminus of the polypeptide.
Noteworthy was a glutamic acid-rich sequence (13.2%), particularly six successive glutamic acids (Glu-84-Glu-89). A motif sequence search showed that acidic poly-Glu was relatively ubiquitous in parathymosin, bone morphogenetic protein, Na ϩ ͞H ϩ exchanger ␤, CD20, L-͞N-myc, HOX-A2͞A7͞ B7, and so forth. A Pro͞Ser͞Thr-rich PT box (positions 91-104) was found in the carboxyl-and amino-terminal domain of thrombopoietin (25) and GM-CSF (26), respectively. Their functional significance is not clear.
Northern blot analysis was carried out to elucidate the types of cells expressing SCGF mRNA. Hybridization of total or poly(A) ϩ RNA from miscellaneous cells with pSHDM(116-10C) cDNA fragments demonstrated that a single 1.8-kb mRNA was expressed in KPB-M15, HL-60, THP-1, U-937, HEL, NHF, and CCD-8Lu cells, but not in K562, MOLT-4, U266Bl, IM-9, HeLa S3, A431, Bowes, and 293 cells (Fig. 4A) ; in particular, no transcript was identified in the 20 g͞lane poly(A) ϩ RNA from K562 and MOLT-4 cells (data not shown). G-CSF (27) , IL-11 (24) , and thrombopoietin (28) are all hematopoietic growth factors, for which mRNA has been detected in myeloid cells and fibroblasts, but not in lymphocytes. This implies that SCGF is a growth factor functioning within the hematopoietic microenvironment. Low-level expression of SCGF mRNA species of 1.6 kb was widespread throughout the tissues examined (Fig. 4B) ; an additional 2.6-kb transcript was noted in the heart. SCGF was partially purified from KPB-M15-CM by sequential DEAE-Sephacel (pH 6) and Cu 2ϩ chelatingSepharose column chromatography, and applied to Sephacryl S-200HR gel filtration. Two elution peaks of 29 and 58 kDa were obtained (Fig. 5) ; the former roughly corresponded to the molecular mass predicted from the SCGF amino acid sequence, and the latter was most likely a homodimer of the former, because the elution peak was not bimodal in DEAE-Sephacel and Cu 2ϩ chelating-Sepharose column chromatography (data not shown). It is presently unclear, however, whether KPB-M15-CM contains another SCGF-like factor.
The effects of rhSCGF on surface phenotype-sorted hematopoietic progenitor cells are currently being investigated. Murine SCGF, if available in the future, could be a useful tool for elucidating the mechanisms of primitive hematopoiesis in conjunction with SCF, flk-2͞flt3 L, IL-1, IL-3, IL-6, IL-11, G-CSF, and GM-CSF. The SHDM vector devised in the present study could be applied to the search for other novel genes by expression cloning. Clinically, in vivo administration of SCGF should ameliorate myelosuppression after irradiation or chemotherapy, or hematopoietic insufficiency including aplastic anemia, myelodysplastic syndrome, and leukemia. Elucidating the mechanisms of SCGF production should help to establish the pathogenesis of hematological disorders.
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